Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

This study has been completed.
Information provided by:
UCB Pharma Identifier:
First received: September 9, 2005
Last updated: December 5, 2013
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2005
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)